| abstract |
The present invention provides a pharmaceutical composition for use as art NPY Y5 receptor antagonist comprising a compound or the formula (I): n n n n n n n n n n n n wherein R 1 is lower alkyl, cycloalkyl or the like, n R 2 is hydrogen, lower alkyl or the like, n n is 1 or 2, n X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, n Y is CONR 7 , CSNR 7 , NR 7 CO, NR 7 CS or the like, n Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like and R 7 is hydrogen or lower alkyl, n prodrug, pharmaceutically acceptable salt or solvate thereof. |